会社概要
| 会社名 | アズリリス株式会社 |
| 本社 | 〒160-0023 東京都新宿区西新宿1-20-3 西新宿高木ビル 7F/8F TEL: 03-6890-3356 |
| 設立 | 2025年 (令和7年) 4月1日 |
| 代表 | 代表取締役CEO 冨成 祐介 |
| 資本金 | 10百万円 ＊2025年4月1日時点 |
| 役職員数 | 2名 ＊2025年5月7日時点 |
| 事業内容 | 医薬品の研究開発 |
沿革
| 年月 | 概要 |
|---|---|
| 2025年4月 | 東京都新宿区において当社設立 |
 |
Ruri Ishikawa, MBA Co-founder, Chief Financial Officer |
| Ruri Ishikawa is the Co-founder and Chief Financial Officer (CFO) of Azuriris, Inc., where she leads the company’s finance, administration, and business strategy. Prior to co-founding Azuriris, she worked at a global venture capital firm in the United States, where she was engaged in corporate venture capital investment activities. She holds an MBA and an MSc in Business Analytics from Hult International Business School. She began her professional career in healthcare, gaining five years of clinical experience as a registered nurse. She earned her nursing degree from Kameda Medical University in 2017 and obtained her nursing license the same year. Over the course of her career, she has developed a multidisciplinary background that spans clinical practice, business strategy, and venture investment. Motivated by a strong desire to move from delivering direct patient care to enabling the development of innovative therapies, she plays a central role in shaping Azuriris’s mission and long-term growth. |
|
